Sign up to save your podcasts
Or
Share GeoVax CEO to Present at 37th Annual Roth Conference
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GeoVax CEO to Present at 37th Annual Roth Conference
GeoVax Labs, a biotechnology company focused on developing immunotherapies and vaccines, will have its CEO present at the 37th Annual Roth Conference. The company will also host investor meetings and discuss its lead clinical programs in COVID-19 and oncology.
View all episodes
GeoVax Labs, a biotechnology company focused on developing immunotherapies and vaccines, will have its CEO present at the 37th Annual Roth Conference. The company will also host investor meetings and discuss its lead clinical programs in COVID-19 and oncology.